Csenge Advisory Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$674K Sell
9,531
-325
-3% -$24.3K 0.03% 378
2025
Q4
$778K Sell
9,856
-96
-1% -$7.6K 0.04% 349
2025
Q3
$820K Sell
9,952
-2,416
-20% -$190K 0.04% 332
2025
Q2
$972K Sell
12,368
-1,279
-9% -$98.7K 0.05% 270
2025
Q1
$990K Buy
13,647
+131
+1% +$10.9K 0.06% 249
2024
Q4
$1.11M Buy
13,516
+1,095
+9% +$91.1K 0.06% 250
2024
Q3
$1.06M Sell
12,421
-336
-3% -$25.1K 0.06% 255
2024
Q2
$895K Sell
12,757
-296
-2% -$21.1K 0.05% 277
2024
Q1
$967K Buy
13,053
+374
+3% +$26.1K 0.05% 270
2023
Q4
$838K Buy
12,679
+450
+4% +$28.2K 0.05% 270
2023
Q3
$769K Sell
12,229
-1,687
-12% -$105K 0.05% 264
2023
Q2
$787K Buy
13,916
+845
+6% +$46.9K 0.05% 268
2023
Q1
$757K Sell
13,071
-3,817
-23% -$258K 0.05% 258
2022
Q4
$1.22M Buy
16,888
+93
+0.6% +$6.66K 0.09% 186
2022
Q3
$1.02M Sell
16,795
-1,442
-8% -$92.1K 0.08% 198
2022
Q2
$1.15M Sell
18,237
-130
-0.7% -$8.61K 0.1% 185
2022
Q1
$1.29M Sell
18,367
-2,370
-11% -$160K 0.1% 174
2021
Q4
$1.25M Sell
20,737
-188
-0.9% -$11.8K 0.11% 157
2021
Q3
$1.31M Buy
20,925
+188
+0.9% +$11.3K 0.11% 168
2021
Q2
$1.25M Buy
20,737
+8,625
+71% +$547K 0.11% 157
2021
Q1
$750K Buy
12,112
+4,186
+53% +$231K 0.08% 195
2020
Q4
$372K Buy
7,926
+934
+13% +$40.5K 0.04% 281
2020
Q3
$268K Sell
6,992
-15,892
-69% -$603K 0.04% 314
2020
Q2
$836K Buy
22,884
+8,244
+56% +$287K 0.12% 136
2020
Q1
$448K Buy
14,640
+2,119
+17% +$94K 0.12% 157
2019
Q4
$638K Buy
12,521
+3,411
+37% +$165K 0.16% 124
2019
Q3
$429K Sell
9,110
-1,853
-17% -$88.3K 0.12% 163
2019
Q2
$544K Buy
+10,963
New +$515K 0.19% 90
2018
Q4
Sell
-106
Closed -$4K 944
2018
Q3
$4K Buy
+106
New +$4.84K ﹤0.01% 650

Other funds holding MET

Csenge Advisory Group's MET Position: Q1 2026 in Review

Csenge Advisory Group reduced its MetLife (MET) stake by 3.3% in Q1 2026, selling an estimated $24.3K and leaving 9,531 shares worth $674K. The position accounts for 0.03% of the portfolio, ranked #378.

Csenge Advisory Group first reported a position in MET in Q3 2018 and has held it in 29 quarters since. The position peaked at $1.31M in Q3 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Csenge Advisory Group held 9,531 shares of MetLife worth $674K as of Q1 2026.
  • Csenge Advisory Group sold 325 MetLife shares in Q1 2026, an estimated $24.3K.
  • MetLife made up 0.03% of Csenge Advisory Group's portfolio in Q1 2026, its #378 holding.
  • Csenge Advisory Group first reported a position in MetLife in Q3 2018 and has held it in 29 quarters since.
  • Csenge Advisory Group's MetLife position peaked at $1.31M in Q3 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.